Misoprosol tablet consistency evaluation has been accepted China Resources, Xianyu rush to attack

Pharmaceutical Network August 15th, August 14th, Sendo Pharmaceuticals issued a notice that the company's misoprostol tablet consistency evaluation has been accepted, is currently under review and approvalAccording to minenet data, so far, the reproductive urinary system and sex hormone drugs over-rated products up to six, including 1 personality hormone and reproductive system regulator, 5 urinary system drugsMisoprosol tablets belong to other gynecological drugs, at present, the sub-category has no products through or see through consistency evaluationTable 1: So far reproductive urinary system and sex hormone drugs over-evaluation product sits
(source: Minet MED China Drug Review Database 2.0)Table 2: Supplemental application for reproductive urinary system and sex hormone drug consistency evaluation under review
(source: Minet MED China Drug Review Database) 2.0)meters of intranet data show that, as of now, the review and approval of reproductive urinary system and sex hormone drug consistency evaluation supplementary applications involving 7 products, of which urinary system drugs are still hot, accounting for 4 seats, sex hormones and reproductive system regulators have two products, other gynecological drugs have one productmisoprostol is a prostaglandin E1 analogue, developed by Searle (now Pfizer) in 1973, and its tablets were first licensed in 1984 for the prevention and treatment of stomach and duodenal ulcersBecause of its contraction characteristics, it has also been widely used in pregnancy and pregnancy women's various indications, such as drug abortion, uterine cervical maturation, pre-surgery softening of the cervixthe misoprostol tablets of Xenon Pharmaceuticals were approved for the market on December 19, 2008, and the indications are "a combination of this product and mifiprostode sequence, which can be used to terminate an early pregnancy within 49 days of menopause"The company said it would actively promote follow-up work, such as a successful consistency rating will increase its market competitivenessUp to now, Misoprosol tablet consistency evaluation supplementary application in the review of theenterprisesas well as China Resources Purple Bamboo Pharmaceuticals, who will break out, we wait for the resultsSources: Announcement of Listed Companies, Internet DatabaseStatistics as of August 14, 2019